Michigan State aligns with Cardinal Health on radio-pharmacy
Michigan State University (MSU) will work with Cardinal Health to open a new radio-pharmacy on campus, allowing access to nuclear imaging agents created at MSU’s medical cyclotron, according to a press release from MSU.
The imaging agents created at MSU decay very quickly and lose potency, so patient-specific doses must get to hospitals and clinics quickly, according to Tom Cooper, interim chair of MSU’s department of radiology. MSU has been operating its medical cyclotron for seven years, allowing the university HealthTeam access to imaging agents to provide on-site PET scans, said Cooper.
Scientists at the university develop a number of nuclear isotopes used in imaging agents for detecting serious illnesses such as cancer, heart disease and neurological disorders. The agents created at MSU are also shipped to pharmacies in Flint and Grand Rapids, Mich. for distribution.
The Dublin, Ohio-based Cardinal Health now will run the new MSU radio-pharmacy, according to the release, creating and distributing the agents to imaging centers through the state.
The imaging agents created at MSU decay very quickly and lose potency, so patient-specific doses must get to hospitals and clinics quickly, according to Tom Cooper, interim chair of MSU’s department of radiology. MSU has been operating its medical cyclotron for seven years, allowing the university HealthTeam access to imaging agents to provide on-site PET scans, said Cooper.
Scientists at the university develop a number of nuclear isotopes used in imaging agents for detecting serious illnesses such as cancer, heart disease and neurological disorders. The agents created at MSU are also shipped to pharmacies in Flint and Grand Rapids, Mich. for distribution.
The Dublin, Ohio-based Cardinal Health now will run the new MSU radio-pharmacy, according to the release, creating and distributing the agents to imaging centers through the state.